Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases.

Papamichael K, Stocco G, Ruiz Del Agua A

Open source

DOI
10.1097/ftd.0000000000001095
Published
2023 Oct 1
Container
Therapeutic drug monitoring
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/ftd.0000000000001095,
  title = {Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases.},
  author = {Papamichael K and Stocco G and Ruiz Del Agua A},
  year = {2023},
  journal = {Therapeutic drug monitoring},
  doi = {10.1097/ftd.0000000000001095},
  url = {https://doi.org/10.1097/ftd.0000000000001095}
}

RIS

TY  - JOUR
TI  - Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases.
AU  - Papamichael K
AU  - Stocco G
AU  - Ruiz Del Agua A
PY  - 2023
JO  - Therapeutic drug monitoring
DO  - 10.1097/ftd.0000000000001095
UR  - https://doi.org/10.1097/ftd.0000000000001095
ER  - 

APA

K, P., G, S., & A, R. D. A. (2023). Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases.. Therapeutic drug monitoring. https://doi.org/10.1097/ftd.0000000000001095

Source records